MBP and measles: According to the literatures, three different groups of biomarkers including laboratory biomarkers, commonly body fluids (i.e., oligoclonal bands (OCB), measles-rubella-zoster (MRZ), kappa-free light chains (kFLCs), CXCL13, neurofilament light chain (NfL), autoantibodies to myelin basic protein (anti-MBP) and vitamin D); markers obtained from imaging technologies (i.e., MRI); and genetic–immunogenetic markers, which are related to genetics and immunogenetics (i.e., circulating MicroRNAs (miRNAs)) have been determined for MS disease [47,48].